These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 81328)

  • 21. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hemostasis in untreated acute leukemia. II. Natural inhibitors: biological and immunological activity. Immunologic variation of antithrombin III].
    Kordich L; Sassetti B; Lago O
    Sangre (Barc); 1984; 29(2):133-40. PubMed ID: 6206579
    [No Abstract]   [Full Text] [Related]  

  • 23. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Coagulation and fibrinolysis in pregnancy].
    Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
    Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinolysis and antithrombin in acute leukaemia.
    Laursen B
    Dan Med Bull; 1976 May; 23(2):81-6. PubMed ID: 59658
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antithrombin III and fibrinolysis during pregnancy and oral contraceptive therapy].
    Laursen B; Herbst TV; Ewald EC; Pedersen SC
    Ugeskr Laeger; 1976 Feb; 138(6):344-8. PubMed ID: 56073
    [No Abstract]   [Full Text] [Related]  

  • 29. Perturbation of protease inhibitors and substrates in inflammatory arthritis.
    Rothschild BM; Thompson LD; Pifer DD; Chesney CM
    Semin Thromb Hemost; 1985 Oct; 11(4):394-404. PubMed ID: 2416060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The coagulation and fibrinolysis activities of the blood during various phases of labor].
    Schander K; Wahl W; Rehm A
    Fortschr Med; 1979 Oct; 97(38):1696-702. PubMed ID: 92443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behavior of various blood coagulation and hemorrheological parameters in arteriosclerotic vascular disease of the lower legs].
    Avellone G; Mandalà V; Novo S; Pinto A; Davì G; Raneli G; Strano A
    Ric Clin Lab; 1983; 13 Suppl 3():297-301. PubMed ID: 6200915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Loss of inhibitors of the blood coagulation system in protein-losing enteropathy (author's transl)].
    Muntean W; Rossipal E
    Klin Padiatr; 1979 Jan; 191(1):20-3. PubMed ID: 310494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrinolysis and the cold pressor test].
    Quartarone M; Di Cesare E; Saitta A; Cucinotta D; Coppolino E; Squadrito G
    Boll Soc Ital Cardiol; 1978; 23(2):412-21. PubMed ID: 89853
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rehabilitation in myocardial infarct. Study of various coagulation parameters and platelet function].
    Gibelli A; Fiorini GF; Renoldi P; Schweiger C; Piazza A; Paracchini ML
    Minerva Med; 1983 May; 74(21):1279-84. PubMed ID: 6190108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pi phenotypes of alpha-1-antitrypsin and antiproteases in meningococcal sepsis].
    Ruiz C; Blanco Quirós A; Solís P; Alvarez Guisasola J; Sánchez Villares E
    An Esp Pediatr; 1983 Oct; 19(4):268-78. PubMed ID: 6197915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood coagulation and fibrinolysis inhibitory factors].
    Imaoka S; Sasaki Y; Terasawa T
    Rinsho Byori; 1985 Jun; Spec No 63():55-61. PubMed ID: 2413229
    [No Abstract]   [Full Text] [Related]  

  • 37. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Disorders of blood coagulatiion during haemoperfusion (author's transl)].
    Niessner H; Pichler M
    Wien Klin Wochenschr; 1977 May; 89(10):347-50. PubMed ID: 68628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. fibrinolysis=fibronolysis.
    Mitchell GA
    Semin Thromb Hemost; 1983 Oct; 9(4):268-80. PubMed ID: 6362010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.